Zenas BioPharma (ZBIO) executive compensation, 2026 proxy

Leon O. Moulder, Jr., Founder, Chief Executive Officer and Chairman, was paid $4.7M in 2025, down 77% from $20M the year before.

Filed
March 16, 2026
Annual meeting
May 11, 2026
Pay year
2025
Named executives
3
CEO total pay
$4.7M-77% vs prior year
CEO Base Salary
$520,000Effective January 1, 2025
CEO Target Bonus %
55%Of base salary
Corporate Achievement
130%Of target for 2025

How Jr. was paid

$4.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary11%Option awards81%Non-equity incentive8%

Named executive officers

ExecutiveTotal
Leon O. Moulder, Jr.Founder, Chief Executive Officer and Chairman$4,661,000
Joseph L. FarmerPresident and Chief Operating Officer$2,526,525
Lisa von Moltke, M.D.Head of Research and Development and Chief Medical Officer$3,499,447

What changed and why

  • $20MChief executive officer total compensation decreased from $19,998,016 in 2024 to $4,661,000 in 2025 primarily due to lower option awards values.
  • 130%Corporate performance goals for 2025 were achieved at 130% of target.
  • $520KNamed executive officers received annual base salaries of $520,000.
  • Long-term incentives were awarded in the form of stock options subject to a four-year vesting schedule.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.